[Skip to Navigation]
Sign In
May 2, 2019

Errors in Tables 2 and 3 and Results Section

JAMA Ophthalmol. 2019;137(7):856. doi:10.1001/jamaophthalmol.2019.1384

In the Original Investigation titled, “Association Between the Cilioretinal Artery and Choroidal Neovascularization in Age-Related Macular Degeneration: A Secondary Analysis From the Age-Related Eye Disease Study,”1 published online July 5, 2018, there were several errors in Tables 2 and 3 as well as an error in the Results section. The column header for odds ratio (OR) in Tables 2 and 3 should be “Adjusted OR (95% CI),” rather than crude OR. There was a formatting error in Table 3 affecting the OR and P values. The correct OR (95% CI) and P values as stated in the manuscript are 1.28 (1.00-1.64), P = .049 for “No Late AMD,” 0.75 (0.56-1.00); P = .05 for “CNV,” and 0.83 (0.56-1.23), P = .35 for “CGA.” The next-to-last sentence in the Results section has a typographical error affecting the change in age-related macular degeneration (AMD) severity score and should read, “however, we found no clear difference in rates of CNV development (1.9% vs 2.5%; P = .44), CGA (1.8% vs 2.3%; P = .45), or change in AMD severity score (0.51 vs 0.59; P = .18) (Table 4).” Finally, instead of the natural exponential of the linear regression coefficient from the multivariate regression model for scale variables, the OR values for AMD severity score from Tables 2 and 3 have been replaced with mean difference (95% CI), which are “−0.18 (−0.32 to −0.03)” for Table 2 and “−0.08 (−0.17 to 0.02)” for Table 3. This article was corrected online.

Snyder  K, Yazdanyar  A, Mahajan  A, Yiu  G.  Association between the cilioretinal artery and choroidal neovascularization in age-related macular degeneration: a secondary analysis from the age-related eye disease study.  JAMA Ophthalmol. 2018;136(9):1008-1014. doi:10.1001/jamaophthalmol.2018.2650PubMedGoogle ScholarCrossref